The contraction of the human pulmonary artery by LTC4 is resistant to CysLT1 antagonists and counteracted by prostacyclin release

Advances in Experimental Medicine and Biology

Volumn 507, Issue , 2002, Pages 315-319

  Bäck, Magnus ^a   Norel, Xavier ^b   Walch, Laurence ^b   Gascard, Jean Pierre ^b   Dahlén, Sven Erik ^a   Brink, Charles ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; LEUKOTRIENE C4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NORADRENALIN; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE INHIBITOR; VERLUKAST; ZAFIRLUKAST; CYSTEINE; LEUKOTRIENE;

ADULT; AGED; ARTERY CONSTRICTION; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PULMONARY ARTERY; STATISTICAL SIGNIFICANCE; ARTICLE; DRUG EFFECT; KINETICS; LUNG TUMOR; MIDDLE AGED; MUSCLE CONTRACTION; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR SMOOTH MUSCLE;

ADULT; AGED; CYSTEINE; HUMANS; INDOMETHACIN; KINETICS; LEUKOTRIENE C4; LEUKOTRIENES; LUNG NEOPLASMS; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PULMONARY ARTERY;

EID: 18844481524     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0193-0_48     Document Type: Conference Paper

References (16)

1. 4 in the guinea-pig ileum, Eur J Pharmacol. 317:107.
2. 4, Fundam Clin Pharmacol. 1:433.
3. 4. J Pharmacol Exp Ther. 237:558.
4. Coleman, R.A., Eglen, R.M., Jones, R.L., Narumiya, S., Shimizu, T., Smith, W.L., Dahlén, S.E., Drazen, J.M., Gardiner, P.J., Jackson, W.T., Jones, T.R., Krell, R.D. and Nicosia, S., 1995, Prostanoid and leukotriene receptors: a progress report from the IUPHAR working parties on classification and nomenclature. Adv Prostaglandin Thromboxane Leukot Res. 23:283.
5. Dahlén, S.E., 1998, Leukotriene receptors: incompletely defined targets for treatment of asthma and inflammation, in: Five-lipoxygenase Products in Asthma, J.M. Drazen, S.E. Dahlén, T.H. Lee, eds., Marcel Dekker, New York.
6. 4 in the rat lung, J Appl Physiol. 73:955.
7. Drazen, J.M., Israel, E. and O'Byrne, P.M., 1999, Treatment of asthma with drugs modifying the leukotriene pathway, N Engl J Med. 340:197.
8. Gaine, S.P. and Rubin, L.J., 1998, Primary pulmonary hypertension, Lancet 352:719.
9. 4 receptor antagonist, Can J Physiol Pharmacol. 67:17.
10. Krell, R.D., Aharony, D., Buckner, C.K., Keith, R.A., Kusner, E.J., Snyder, D.W., Bernstein, P.R., Matassa, V.G., Yee, Y.K., Brown, F.J., Hesp, B. & Giles, R.E., 1990, The preclinical pharmacology of ICI 204,219, Am Rev Respir Dis. 141:978.
11. Labat, C., Ortiz, J.L., Norel, X., Gorenne, I., Verley, J., Abram, T.S., Cuthbert, N.J., Tudhope, S.R., Norman, P., Gardiner, P. and Brink, C., 1992, A second cysteinyl leukotriene receptor in human lung. J Pharmacol Exp Ther. 263:800.
12. Ortiz, J.L., Gorenne, I., Cortijo, J., Seller, A., Labat, C., Sarria, B., Abram, T.S., Gardiner, P.J., Morcillo, E. and Brink, C., 1995, Leukotriene receptors on human pulmonary vascular endothelium. Br J Pharmacol. 115:1382.
13. 4 on human airway smooth muscle cell proliferation, matrix expression, and contraction in vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists, Am J Respir Cell Mol Biol. 19:453.
14. Schellenberg, R.R. and Foster, A., 1984, Differential activity of leukotrienes upon human pulmonary vein and artery, Prostaglandins 27:475.
15. 4 in neonates with hypoxemia and pulmonary hypertension, N Engl J Med. 309:77.
16. Walch, L., Labat, C., Gascard, J.P., de Montpreville, V., Brink, C. and Norel, X., 1999, Prostanoid receptors involved in the relaxation of human pulmonary vessels. Br J Pharmacol. 126: 859.